Medicure Inc. is pleased to announce that, following a comprehensive strategic review and formal process, as first announced in the press release of January 13, 2010, the Company has completed the following transactions:
News & Media
Valeant Pharmaceuticals announced plans Friday to shift its U.S. production to Quebec as it continued a shopping spree to become the world's largest dermatological treatment company
The Honourable Rona Ambrose, Minister of Public Works and Government Services and Minister for Status of Women, is pleased to announce that the Government of Canada is once again accepting applications from local businesses to help kickstart their innovat
Medicure International and Iroko Cardio Sign an Agreement for the Advancement of AGGRASTAT® Worldwide
Medicure Inc. announced that its subsidiary, Medicure International, Inc. and Iroko Cardio, LLC have entered into an agreement to advance AGGRASTAT® (tirofiban HCl) in each of their respective territories
Monteris Medical Inc. announced that it has concluded an $8.6 million financing led by the Business Development Bank of Canada.
Manitoba's Composites Innovation Centre (CIC) and Minnesota's Chopper College have partnered to create a commercial-scale, eco-friendly, high performance motorcycle--powered by biofuels and enhanced with bio-composite parts developed by the CIC.
Cangene announced that the Biomedical Advanced Research and Development Authority will exercise options under a botulism antitoxin supply contract, which are expected to generate approximately US$61 million in additional revenue for Cangene over the next
The LSAM job posting page connects qualified candidates eager to succeed in the life sciences to member organizations with open positions.
Province, University of Manitoba, GlaxoSmithKline Establish Endowed Research Chair to Study Infectious Disease
The creation of Manitoba’s first-ever research chair in the immunobiology of infectious disease at the University of Manitoba will further develop the province’s internationally-recognized expertise in infectious disease research.
Kane Biotech Inc. has won a significant new contract with a U.S. army medical research facility that will leverage other development opportunities for the firm.
New Program to Promote Business, Economic Growth: Province Will Invest $30 Million Over Five Years --Selinger
A new, $30-million Commercialization Support for Business Program has been established to promote and support entrepreneurism, commercialization and business development, Premier Greg Selinger announced
The Province of Manitoba and Manitoba Hydro are entering an agreement with Nissan Canada to work together on initiatives that will help advance the use of plug-in electric vehicles in the province, Innovation, Energy and Mines Minister Dave Chomiak announ
Valeant agreed to buy AB Sanitas for about 314 million euros ($442 million) to add dermatology drugs in eastern and central Europe
The Food Development Centre (FDC) is working with the Manitoba Agri-Health Research Network to make food a part of a treatment process to improve quality of life. Along with two other organizations working with the support of MAHRN (the Canadian Centre fo
The Richardson Centre for Functional Foods and Nutraceuticals is five years old and to mark the occasion it was joined by the Honourable Erin Selby, Minister of Advanced Education and Literacy, as it signed two international research agreements
The Sanford Project & DiaMedica announced the successful completion of a study involving DM-199 in preventing the onset of Type 1 diabetes in the non-obese diabetic mouse model
GVI Clinical Development Solutions Inc. and Guangzhou, China based Guangzhou IRD Medicine Company, announce the signing of a Memorandum of Understanding to create a joint venture company called IRD-CDS, based in China
Premier Greg Selinger announced a new Science Education Action Plan that includes $25 million over five years for science classroom renewal, teacher training and new strategic partnerships to promote Manitoba's science programming
Regulations for foods and natural health products, and what you can say about them, vary from country to country.
DiaMedica announced the company's entry into an evaluation agreement with the National Institute of Allergy and Infectious Diseases, a component of the U.S. National Institutes of Health
Valeant filed with the Securities and Exchange Commission a presentation in connection with its written consent solicitation to stockholders of Cephalon, Inc. for removal of Cephalon's current Board of Directors and election of its seven nominees in their